10 mg retatrutide 10mg — Triple Receptor Agonist (GLP-1 / GIP / Glucagon) — – Prime Labs GLP3 – Reta (10mg) |

All PlexusDx medications are from licensed 503A compounding pharmacies and are available in all 50 states with no insurance required

Glucagon, the receptor retatrutide brings to the table, is the surprising one: on its own you might expect it to raise blood sugar, but paired with the incretin receptors it appears to lift energy expenditure, which is a different lever entirely

11,12,19 Liraglutide appears to have the highest proportion of severe GI AEs, and dulaglutide shows the lowest

Retatrutide (LY3437943) is Eli Lillys experimental triple-agonist drug that activates: GLP-1 (Glucagon-like peptide-1) reduces appetite and slows digestion GIP (Glucose-dependent insulinotropic peptide) enhances insulin sensitivity Glucagon receptor increases fat metabolism and energy expenditure In phase-2 trials, Retatrutide achieved up to 24% body-weight reduction rivaling or even surpassing bariatric surgery outcomes